Abstract |
A late Phase II multicenter study with menogaril was conducted nationwide in patients with malignant lymphoma [ non-Hodgkin's lymphoma (NHL), Hodgkin's disease (HD)], and ATLL, menogaril was orally administered at 100 mg daily after breakfast, for seven consecutive days with two- or three-week drug withdrawal, then menogaril administration was repeated. For malignant lymphoma, in 81 patients with NHL and 5 patients with HD registered, 70 and 5 patients were evaluable for efficacy, respectively. The efficacy rates were 32.9% (6 CRs + 17 PRs/70) for NHL and 20.0% (1 PR/5) for HD, respectively; that for the NHL patients with prior anthracycline antibiotic chemotherapy was 30.5% (5 CRs and 13 PRs/59). For ATLL, among the 16 patients registered, 15 were evaluable for efficacy, and the efficacy rate was 40.0% (2 CRs and 4 PRs/15). Adverse drug reactions frequently observed in the patients with malignant lymphoma and ATLL included bone-marrow suppression and gastrointestinal symptoms such as anorexia, and nausea/ vomiting. With these results, menogaril was considered to be effective for the treatment of non-Hodgkin's lymphoma and ATLL.
|
Authors | T Taguchi, K Ohta, T Hotta, S Shirakawa, T Masaoka, I Kimura |
Journal | Gan to kagaku ryoho. Cancer & chemotherapy
(Gan To Kagaku Ryoho)
Vol. 24
Issue 10
Pg. 1263-71
(Aug 1997)
ISSN: 0385-0684 [Print] Japan |
PMID | 9279345
(Publication Type: Clinical Trial, Clinical Trial, Phase II, English Abstract, Journal Article, Multicenter Study)
|
Chemical References |
- Antibiotics, Antineoplastic
- Menogaril
|
Topics |
- Administration, Oral
- Adult
- Aged
- Anorexia
(chemically induced)
- Antibiotics, Antineoplastic
(administration & dosage, adverse effects)
- Bone Marrow
(drug effects)
- Drug Administration Schedule
- Female
- Hodgkin Disease
(drug therapy)
- Humans
- Leukemia-Lymphoma, Adult T-Cell
(drug therapy)
- Lymphoma, Non-Hodgkin
(drug therapy)
- Male
- Menogaril
(administration & dosage, adverse effects)
- Middle Aged
- Nausea
(chemically induced)
- Vomiting
(chemically induced)
|